International Chemical Investors (ICIG) has successfully completed the acquisition of the compounds business of Benvic Group SAS from PVC Europe Group S.a.r.l, an investment subsidiary of Investindustrial. Benvic develops, produces and markets thermoplastic solutions based on PVC as well as engineering polymers and bio-polymers compounds. With approximately €500 million of sales and 630 full time employees (FTEs), the company is one of Europe’s leading PVC compounders in terms of volume as well as a leader in several specialty compounding applications in the US. Benvic will form the basis for a new “Compounds” platform within ICIG and will continue to operate under the “Benvic” branding and market approach. The signing of the transaction was announced in late August and has since received all customary approvals. Founded in 1963 as a subsidiary of Solvay, Benvic develops, produces and markets highly customized, innovative thermoplastic solutions base...

PVC Europe Group S.a.r.l (Investindustrial), an independently managed investment subsidiary of Investindustrial Growth L.P. (Growth Fund), has signed a binding put option for the sale of the compounds business (Benvic Compounds) of Benvic Group SAS (Benvic) to the strategic investor, International Chemical Investors Group (ICIG), subject to the consultation of Benvic’s works council in France and EU anti-trust approval. Closing is expected towards the end of the year. Benvic’s medical activities in Italy are expected to be retained by Investindustrial funds. Benvic Compounds develops, produces and markets thermoplastic solutions based on PVC as well as engineering polymers and bio-polymers compounds. With approximately €500 million of sales and 630 fulltime employees (FTEs), the company is one of Europe’s leading PVC compounders in terms of volume as well as a leader in several specialty compounding applications in the US. Since Investindustrial&rsquo...